Integrated Diagnostics Holdings Stock Return On Equity
| IDHC Stock | 0.45 0.02 4.65% |
Integrated Diagnostics Holdings fundamentals help investors to digest information that contributes to Integrated Diagnostics' financial success or failures. It also enables traders to predict the movement of Integrated Stock. The fundamental analysis module provides a way to measure Integrated Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integrated Diagnostics stock.
Integrated | Return On Equity |
Integrated Diagnostics Holdings Company Return On Equity Analysis
Integrated Diagnostics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Integrated Diagnostics Return On Equity | 0.23 |
Most of Integrated Diagnostics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integrated Diagnostics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Integrated Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Integrated Diagnostics Holdings has a Return On Equity of 0.2303. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United Kingdom stocks is notably lower than that of the firm.
Integrated Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integrated Diagnostics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integrated Diagnostics could also be used in its relative valuation, which is a method of valuing Integrated Diagnostics by comparing valuation metrics of similar companies.Integrated Diagnostics is currently under evaluation in return on equity category among its peers.
Integrated Fundamentals
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0969 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 251.31 M | ||||
| Shares Outstanding | 581.33 M | ||||
| Shares Owned By Insiders | 33.97 % | ||||
| Shares Owned By Institutions | 42.29 % | ||||
| Price To Book | 4.59 X | ||||
| Price To Sales | 0.06 X | ||||
| Revenue | 4.12 B | ||||
| Gross Profit | 2.8 B | ||||
| EBITDA | 1.28 B | ||||
| Net Income | 737.36 M | ||||
| Total Debt | 1.18 B | ||||
| Book Value Per Share | 4.64 X | ||||
| Cash Flow From Operations | 543.66 M | ||||
| Earnings Per Share | 0.03 X | ||||
| Target Price | 0.54 | ||||
| Number Of Employees | 6.69 K | ||||
| Beta | 0.45 | ||||
| Market Capitalization | 26.16 B | ||||
| Total Asset | 5.77 B | ||||
| Retained Earnings | 1.28 B | ||||
| Working Capital | 686.94 M | ||||
| Net Asset | 5.77 B |
About Integrated Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integrated Diagnostics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integrated Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integrated Diagnostics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.